The AI arms race utilization management intensifies payer-provider conflicts, raising risks for hospitals and health systems nationwide.

In a field where an algorithm's decision can determine a patient's access to life-saving medication, "black box" AI is an ...

Clinical accountability remains firmly with human providers when utilizing new diagnostic technology for midlife women's ...

This article argues for the adoption of a combined lyophilized plasma and platelet product strategy to address critical gaps.

As ambient documentation and gen AI spread across clinical workflows, healthcare IT leaders are reassessing governance, ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing ...

The data reveals key market opportunities in enhancing compliance through expertise in PMS, PMCF, and vigilance for digital health technologies. Emphasizing real-world data, risk management, and ...

In healthcare, where the cost of care is rising, organizations can’t afford to drive patients away due to inefficient systems ...

The current global health financing emergency is not only creating a service delivery crisis;1 it threatens hard-won health research and life science ecosystems in low-income and middle-income ...

Senior leadership roles at Guardant Health, Genentech and PfizerRegulatory, clinical and commercial expertise in therapeutics and biomarkersWill assist with osteosarcoma regulatory advice and oncology ...

Responding to Hong Kong's aging trend Extending "retirement planning" into "health capital management" HONG KONG SAR - Media ...